ArticleFrontiers in neuroscience2025
Non-obtrusive monitoring of obstructive sleep apnea syndrome based on ballistocardiography: a preliminary study.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Obstructive sleep apnea syndrome (OSAS) degrades sleep quality and is associated with serious health conditions. Instead of the gold-standard polysomnography requiring complex equipment and expertise, a non-obtrusive device such as ballistocardiography (BCG) is more suitable for home-based continuous monitoring of OSAS, which has shown promising results in previous studies. However, often due to the limited storage and computing resource, also preferred by venders, the high computational cost in many existing BCG-based methods would practically limit the deployment for home monitoring. Methods: In this preliminary study, we propose an approach for OSAS monitoring using BCG signals. Applying fast change-point detection to first isolate apnea-suspected episodes would allow for processing only those suspected episodes for further feature extraction and OSAS severity classification. This can reduce both the data to be stored or transmitted and the computational load. Furthermore, our approach directly extracts features from BCG signals without employing a complex algorithm to derive respiratory and heart rate signals as often done in literature, further simplifying the algorithm pipeline. Apnea-hypopnea index (AHI) is then computed based on the detected apnea events (using a random forest classifier) from the identified apnea-suspected episodes. To deal with the expected underestimated AHI due to missing true apnea events during change-point detection, we apply boundary adjustment on AHI when classifying severity. Results: Cross-validated on 32 subjects, the proposed approach achieved an accuracy of 71.9% for four-class severity classification and 87.5% for binary classification (AHI less than 15 or not). Conclusion: These findings highlight the potential of our proposed BCG-based approach as an effective and accessible alternative for continuous OSAS monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.